Inventor · disambiguated record
Zhi-Yong Yang
Also filed as: WANG LEGAL REPRESENTATIVE ZENGGUANG · YANG ZHI-YONG
35 granted patents·31 pending applications·671 citations·filing 1993–2025
98Inventor score
Top patents by PatentIndex Score
66 records- 0197US8454972B2Method for inducing a multiclade immune response against HIV utilizing a multigene and multiclade immunogenNABEL GARY J·Filed 2011·Granted Jun 4, 2013·212 cites·10 claims
- 0296US11192960B2Trispecific and/or trivalent binding proteinsSANOFI SA·Filed 2020·Granted Dec 7, 2021·6 cites·30 claims
- 0396US10882922B2Trispecific and/or trivalent binding proteinsSANOFI SA·Filed 2017·Granted Jan 5, 2021·20 cites·47 claims
- 0496US7094598B2Development of a preventive vaccine for filovirus infection in primatesUS HEALTH·Filed 2004·Granted Aug 22, 2006·43 cites·7 claims
- 0595US11779651B2Bivalent, bispecific binding proteins for prevention or treatment of HIV infectionSANOFI SA·Filed 2021·Granted Oct 10, 2023·2 cites·3 claims
- 0695US11530268B2Trispecific anti-CD38, anti-CD28, and anti-CD3 binding proteins and methods of use for treating viral infectionSANOFI SA·Filed 2019·Granted Dec 20, 2022·15 cites·34 claims
- 0794US11613576B2Trispecific binding proteins, methods, and uses thereofSANOFI SA·Filed 2020·Granted Mar 28, 2023·3 cites·29 claims
- 0894US11186649B2Anti-CD38 antibodies and methods of useSANOFI SA·Filed 2018·Granted Nov 30, 2021·10 cites·41 claims
- 0994US10035844B2Broadly neutralizing HIV-1 VRC07 antibodies that bind to the CD4-binding site of the envelope proteinUS HEALTH·Filed 2017·Granted Jul 31, 2018·6 cites·32 claims
- 1094US8106026B2Development of a preventive vaccine for filovirus infection in primatesNABEL GARY J·Filed 2009·Granted Jan 31, 2012·11 cites·9 claims
- 1193US11129905B2Bivalent, bispecific binding proteins for prevention or treatment of HIV infectionSANOFI SA·Filed 2019·Granted Sep 28, 2021·6 cites·3 claims
- 1293US8637036B2Neutralizing antibodies to HIV-1 and their useMASCOLA JOHN R·Filed 2012·Granted Jan 28, 2014·22 cites·23 claims
- 1393US8323961B2HIV vaccines based on adenoviral vectors encoding Env from multiple clades of HIVNABEL GARY J·Filed 2011·Granted Dec 4, 2012·13 cites·2 claims
- 1493US5863904AMethods for treating cancers and restenosis with P21UNIV MICHIGAN·Filed 1995·Granted Jan 26, 1999·93 cites·8 claims
- 1592US7947822B2HIV vaccines based on Env of multiple clades of HIVUS HEALTH·Filed 2010·Granted May 24, 2011·17 cites·3 claims
- 1691US9695230B2Broadly neutralizing HIV-1 VRC07 antibodies that bind to the CD4-binding site of the envelope proteinUS HEALTH·Filed 2012·Granted Jul 4, 2017·9 cites·41 claims
- 1790US6218372B1Methods for treating restenosis with p21UNIV MICHIGAN·Filed 1999·Granted Apr 17, 2001·70 cites·15 claims
- 1888US8124592B2Development of a preventive vaccine for filovirus infection in primatesNABEL GARY J·Filed 2009·Granted Feb 28, 2012·3 cites·9 claims
- 1988US8106027B2Development of a preventive vaccine for filovirus infection in primatesNABEL GARY J·Filed 2009·Granted Jan 31, 2012·3 cites·9 claims
- 2088US8101739B2Recombinant expression vectors comprising a human codon-optimized marburg virus (MARV) angola glycoprotein gene insert and method of immunization employing said vectorSULLIVAN NANCY·Filed 2005·Granted Jan 24, 2012·10 cites·8 claims
- 2187US9012618B2Nucleic acids encoding modified Ebola virus glycoproteins with diminished cytotoxicity while retaining native antigenic structuresSULLIVAN NANCY·Filed 2012·Granted Apr 21, 2015·5 cites·8 claims
- 2287US6057300AMethods for treating cancers and restenosis with p21UNIV MICHIGAN·Filed 1998·Granted May 2, 2000·56 cites·3 claims
- 2386US2025312475A1Bivalent, bispecific binding proteins for prevention or treatment of hiv infectionSANOFI SA·Filed 2024·Application pending·0 cites
- 2485US9738703B2Neutralizing antibodies to HIV-1 and their useUS HEALTH·Filed 2015·Granted Aug 22, 2017·2 cites·21 claims
- 2584US9175070B2Neutralizing antibodies to HIV-1 and their useMASCOLA JOHN R·Filed 2010·Granted Nov 3, 2015·4 cites·7 claims
- 2682US12227573B2Trispecific binding proteins, methods, and uses thereofSANOFI SA·Filed 2023·Granted Feb 18, 2025·0 cites·45 claims
- 2780US10035845B2Neutralizing antibodies to HIV-1 and their useUS HEALTH·Filed 2017·Granted Jul 31, 2018·2 cites·21 claims
- 2880US7635688B2Development of a preventive vaccine for filovirus infection in primatesUS HEALTH·Filed 2002·Granted Dec 22, 2009·6 cites·9 claims
- 2974US2024279362A1Trispecific and/or trivalent binding proteinsSANOFI SA·Filed 2024·Application pending·0 cites
- 3072US2023227553A1Antigen binding polypeptides, antigen binding polypeptide complexes and methods of use thereofMODEX THERAPEUTICS·Filed 2022·Application pending·0 cites
- 3172US2023357401A1Trispecific anti-cd38, anti-cd28, and anti-cd3 binding proteins and methods of use for treating viral infectionSANOFI SA·Filed 2022·Application pending·0 cites
- 3271US7087582B1Combination for site-specifically transforming cells in vivo comprising a double-balloon catheter and nucleic acid comprising a gene encoding P21UNIV MICHIGAN·Filed 2000·Granted Aug 8, 2006·1 cites·18 claims
- 3371US2025250338A1Trispecific binding proteins, methods, and uses thereofSANOFI SA·Filed 2025·Application pending·0 cites
- 3471US2025250337A1Trispecific binding proteins, methods, and uses thereofSANOFI SA·Filed 2025·Application pending·0 cites
- 3571US2023203199A1Antigen binding polypeptides, antigen binding polypeptide complexes and methods of use thereofMODEX THERAPEUTICS·Filed 2022·Application pending·0 cites
- 3671US2023235092A1Antigen binding polypeptides, antigen binding polypeptide complexes and methods of use thereofMODEX THERAPEUTICS·Filed 2022·Application pending·0 cites
- 3770US2008095835A1Methods for treating cancers and restenosis with P21NABEL GARY J·Filed 2007·Application pending·0 cites
- 3866US11932704B2Trispecific and/or trivalent binding proteinsSANOFI SA·Filed 2021·Granted Mar 19, 2024·0 cites·7 claims
- 3966US2005038499A1Methods for coating stents with DNA and expression of recombinant genes from DNA coated stents in vivoFiled 2004·Application pending·0 cites
- 4066US2006239975A1Methods for treating cancers and restenosis with p21NABEL GARY J·Filed 2006·Application pending·0 cites
- 4165US10815295B2Broadly neutralizing HIV-1 antibodies that bind to the CD4-binding site of the envelope proteinUS HEALTH·Filed 2018·Granted Oct 27, 2020·0 cites·6 claims
- 4265US7666427B2HIV vaccines based on Env of multiple clades of HIVUS HEALTH·Filed 2007·Granted Feb 23, 2010·0 cites·42 claims
- 4365US2025161481A1Targeted lnp deliveryMODEX THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 4463US2025197481A1Antigen Binding Polypeptides, Antigen Binding Polypeptide Complexes and Methods of Use Thereof in HIVMODEX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4563US2008112997A1Methods for coating stents with DNA and expression of recombinant genes from DNA coated stents in vivoNABEL ELIZABETH G·Filed 2007·Application pending·0 cites
- 4663US2011177122A1Dna prime/activated vaccine boost immunization to influenza virusUS HEALTH·Filed 2009·Application pending·0 cites
- 4762US2024059798A1Conditionally activated antigen binding polypeptide complexes and methods of use thereofMODEX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4861US2012034254A1Antigenic cloaking and its useKWONG PETER D·Filed 2009·Application pending·0 cites
- 4960US9382311B2HIV-1 broadly neutralizing antibodiesINT AIDS VACCINE INITIATIVE·Filed 2013·Granted Jul 5, 2016·0 cites·8 claims
- 5060US2024109955A1Anti-sars-cov-2 antigen binding polypeptides, polypeptide complexes and methods of use thereofMODEX THERAPEUTICS INC·Filed 2023·Application pending·0 cites
Showing the top 50 of 66 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Zhi-Yong Yang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →